Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

AMLEXANOX

AMLEXANOX

Standard Dose
2MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary

Approval overview AMLEXANOX is listed in Drugs@FDA under application 021727 (NDA).

Review priority: N/A Marketing status: Discontinued Active ingredient AMLEXANOX Form and strength PATCH;TOPICAL - 2MG Sponsor ULURU Submission history Latest submission status date: 2008-11-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMLEXANOX is listed in Drugs@FDA under application 021727 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient AMLEXANOX Form and strength PATCH;TOPICAL - 2MG Sponsor ULURU Submission history Latest submission status date: 2008-11-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.